Search alternatives:
significantly linear » significant linear (Expand Search), significantly lower (Expand Search), significantly longer (Expand Search)
linear decrease » linear increase (Expand Search)
better decrease » greater decrease (Expand Search), teer decrease (Expand Search), between decreased (Expand Search)
significantly linear » significant linear (Expand Search), significantly lower (Expand Search), significantly longer (Expand Search)
linear decrease » linear increase (Expand Search)
better decrease » greater decrease (Expand Search), teer decrease (Expand Search), between decreased (Expand Search)
-
301
-
302
-
303
Estimated infection intensity (mean egg count per gram) for infected stools.
Published 2025Subjects: -
304
-
305
-
306
-
307
Study-related adverse events.
Published 2025“…We recorded 12 study-related, Grade 1–2 AEs and no serious AEs. In a linear mixed model analysis (LMM), the MBSR + PAP arm evidenced a significantly larger decrease in QIDS-SR-16 score than the MBSR-only arm from baseline to 2-weeks post-intervention (between-groups effect = 4.6, 95% CI [1.51, 7.70]; <i>p</i> = 0.008). …”
-
308
Study flow chart.
Published 2025“…We recorded 12 study-related, Grade 1–2 AEs and no serious AEs. In a linear mixed model analysis (LMM), the MBSR + PAP arm evidenced a significantly larger decrease in QIDS-SR-16 score than the MBSR-only arm from baseline to 2-weeks post-intervention (between-groups effect = 4.6, 95% CI [1.51, 7.70]; <i>p</i> = 0.008). …”
-
309
Study CONSORT diagram.
Published 2025“…We recorded 12 study-related, Grade 1–2 AEs and no serious AEs. In a linear mixed model analysis (LMM), the MBSR + PAP arm evidenced a significantly larger decrease in QIDS-SR-16 score than the MBSR-only arm from baseline to 2-weeks post-intervention (between-groups effect = 4.6, 95% CI [1.51, 7.70]; <i>p</i> = 0.008). …”
-
310
-
311
-
312
-
313
-
314
Time course of central retinal thickness (CRT) in recurrence and non-recurrence groups.
Published 2025Subjects: -
315
-
316
Annual number of outpatient visits in recurrence and non-recurrence groups.
Published 2025Subjects: -
317
-
318
-
319
-
320
Time course of best-corrected visual acuity (BCVA) in recurrence and non-recurrence groups.
Published 2025Subjects: